SCHEMBL10399170

SCHEMBL10399170

COC(=O)C=CC=C(c1ccc(OC)cc1)c1ccccc1OC

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 2/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
RAB9A P51151 3/20 0.43
PTAFR P25105 3/20 0.43
STS P08842 1/20 0.42
NPC1 O15118 4/20 0.42
GAA P10253 1/20 0.42
KDM4E B2RXH2 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
ABCG2 Q9UNQ0 1/20 0.42
CTSD P07339 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10399169 1.00 MAOB (0.50) MAOBSMN1; SMN2LMNAKMT2AMEN1
SCHEMBL10399168 1.00 MAOB (0.50) MAOBSMN1; SMN2LMNAKMT2AMEN1
SCHEMBL10398890 0.88 MAOB (0.51) MAOBSMN1; SMN2LMNAKMT2AMEN1
SCHEMBL10398891 0.88 MAOB (0.51) MAOBSMN1; SMN2LMNAKMT2AMEN1
SCHEMBL10399176 0.88 MAOB (0.51) MAOBSMN1; SMN2LMNAKMT2AMEN1
SCHEMBL10398965 0.88 PTAFR (0.50) MAOBSMN1; SMN2RAB9APTAFRNPC1
SCHEMBL10398967 0.88 PTAFR (0.50) MAOBSMN1; SMN2RAB9APTAFRNPC1
SCHEMBL10398671 0.85 CES2 (0.54) MAOBSMN1; SMN2KMT2AMEN1RAB9A
SCHEMBL10398675 0.85 CES2 (0.54) MAOBSMN1; SMN2KMT2AMEN1RAB9A
SCHEMBL10398673 0.85 CES2 (0.54) MAOBSMN1; SMN2KMT2AMEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4975438-A ANTICOAGULANT HOFFMANN-LA ROCHE INC. (US) 1990-12-04 US disclosed
US-4788206-A CARDIOVASCULAR DISORDERS, PLATELETS HOFFMANN-LA ROCHE INC. (US) 1988-11-29 US disclosed